ReviewThe Lancet regional health. Europe2021
Pandemics- One Health preparedness for the next.
Review in The Lancet regional health. Europe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 74 citations in OpenAlex.
- Integrating mathematical modelling and artificial intelligence to combat emerging viral syndemics: A systematic review.New microbes and new infections · 2026Review
- Review
- Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gaps.Cell reports · 2026Article
- Article
- Confronting the known unknown: historical lessons and future strategies for Disease X.Frontiers in public health · 2026Review
- Climate, urbanization, and infectious disease: Environmental drivers of Foshan's chikungunya outbreak.Eco-Environment & Health · 2025Article
- Diversity, equity and inclusion in One Health could crucially support functional health security by fostering prevention, but a change in mindset is needed.One health outlook · 2025Article
- Human mobility and sewage data correlate with COVID-19 epidemic evolution in a 3-year surveillance of the metropolitan area of Bologna.BMC infectious diseases · 2025Article
- To face Disease X: building resilient futures in the age of emergent threats.BMJ global health · 2025Article
- Pandemic preparedness and response priorities in Latin America: A regional Delphi consensus.Public health · 2025Article
- Developing a one health data integration framework focused on real-time pathogen surveillance and applied genomic epidemiology.One health outlook · 2025Article
- Embedding risk monitoring in infectious disease surveillance for timely and effective outbreak prevention and control.BMJ global health · 2025Review
- ABO blood group and COVID-19 severity: Associations with endothelial and adipocyte activation in critically ill patients.PloS one · 2025Article
- The link between antibiotic resistance level and soil physico-chemical properties.Frontiers in microbiology · 2025Article
- Balancing Equity and Global Health Security Towards a Fair and Effective Pandemic Agreement.International journal of public health · 2025Article
- The "pharmakon" of prevention: artificial immunity in the covid-19 pandemic.Historia, ciencias, saude--Manguinhos · 2024Article
- Realising a global One Health disease surveillance approach: insights from wastewater and beyond.Nature communications · 2024Review
- Antimicrobial Resistance and Virulence Potential of Bacterial Species from Captive Birds of Prey-Consequences of Falconry for Public Health.Animals : an open access journal from MDPI · 2024Review
- Multidimensional perspectives of geo-epidemiology: from interdisciplinary learning and research to cost-benefit oriented decision-making.Frontiers in public health · 2024Article
- Detection of SARS-CoV-2 on the environmental surfaces and its implications for pandemic preparedness.Frontiers in public health · 2024Article
Corrections and comments
- Commented on by
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The majority of emerging infectious diseases originate in animals. Current routine surveillance is focused on known diseases and clinical syndromes, but the increasing likelihood of emerging disease outbreaks shows the critical importance of early detection of unusual illness or circulation of pathogens - prior to human disease manifestation. In this Viewpoint, we focus on one key pillar of preparedness-the need for early warning surveillance at the human, animal, environmental interface. The COVID-19 pandemic has revolutionized the scale of sequencing of pathogen genomes, and the current investments in global genomic surveillance offer great potential for a novel, truly integrated Disease X (with epidemic or pandemic potential) surveillance arm provided we do not make the mistake of developing them solely for the case at hand. Generic tools include metagenomic sequencing as a catch-all technique, rather than detection and sequencing protocols focusing on what we know. Developing agnostic or more targeted metagenomic sequencing to assess unusual disease in humans and animals, combined with random sampling of environmental samples capturing pathogen circulation is technically challenging, but could provide a true early warning system. Rather than rebuilding and reinforcing the pre-existing silo's, a real step forward would be to take the lessons learned and bring in novel essential partnerships in a One Health approach to preparedness.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.